QGEN Stock Might Rise on Partnership With Bode for GEDmatch PRO [Yahoo! Finance]
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: Yahoo! Finance
QIAGEN N.V. QGEN recently announced that Bode Technology will be the exclusive global commercial partner for its GEDmatch PRO genealogy database. QIAGEN's subsidiary Verogen inked the deal with Bode. The company has been providing GEDmatch PRO to customers since the acquisition of its subsidiary, Verogen, in early 2023. The latest partnership is aimed at accelerating the use of QIAGEN's next-generation sequencing (NGS) products in human identification (HID) and forensic investigations. QGEN's Likely Stock Trend Following the News Following the news, shares of QGEN remained unchanged at $44.46 in pre-market trading today. The company is gaining a high level of synergies from its continuous development and strategic expansions in the forensics and human identification space through its NGS products. We expect the latest partnership to motivate market sentiment in the coming days. Meanwhile, QGEN currently has a market capitalization of $10.15 billion. In the last reported quart
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- Those who invested in Qiagen (NYSE:QGEN) five years ago are up 41% [Yahoo! Finance]Yahoo! Finance
- QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays [Yahoo! Finance]Yahoo! Finance
- QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assaysGlobeNewswire
- PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samplesGlobeNewswire
- QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy databaseGlobeNewswire
QGEN
Earnings
- 7/31/24 - Beat
QGEN
Sec Filings
- 9/11/24 - Form 144
- 9/4/24 - Form 6-K
- 9/3/24 - Form 6-K
- QGEN's page on the SEC website